Multiple sclerosis

Disease course and outcome of 15 monocentrically treated natalizumab-associated progressive multifocal leukoencephalopathy patients
Stefanie Dahlhaus, Robert Hoepner, Andrew Chan, Ingo Kleiter, Ortwin Adams, Carsten Lukas, Kerstin Hellwig, Ralf Gold

Journal of Neurology, Neurosurgery & Psychiatry Oct 2013, 84 (10) 1068-1074; DOI: 10.1136/jnnp-2013-304897
PATIENT-REPORTED OUTCOMES AND DISABILITY IN MULTIPLE SCLEROSIS
Neil Scolding, Hongwei Wang, Yan Liu, Lawrence Steinman

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.127
SEASON OF GLANDULAR FEVER AS A RISK FACTOR FOR MULTIPLE SCLEROSIS
Christina Downham, Elizabeth Visser, Mark Vickers, Carl Counsell

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.107
EARLY RELAPSES IN PATIENTS WITH HIGHLY ACTIVE MULTIPLE SCLEROSIS COMMENCED ON FINGOLIMOD; THE LEEDS TEACHING HOSPITAL EXPERIENCE
Kalani Chisha Weerasinghe, Priya Shanmugarajah, Melanie Russell, Helen Ford

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.123
Long-term treatment of relapsing-remitting multiple sclerosis with interferon β: how strongly should we encourage patients to adhere to the ‘old’ therapies?
F Heidenreich

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) 1171; DOI: 10.1136/jnnp-2015-310763
Factors influencing long-term outcomes in relapsing–remitting multiple sclerosis: PRISMS-15
Ludwig Kappos, Jens Kuhle, Juha Multanen, Marcelo Kremenchutzky, Elisabetta Verdun di Cantogno, Peter Cornelisse, Lorenz Lehr, Florence Casset-Semanaz, Delphine Issard, Bernard M J Uitdehaag

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) 1202-1207; DOI: 10.1136/jnnp-2014-310024
MANAGEMENT OF FINGOLIMOD FIRST DOSE OBSERVATION (FDO) IN THE UK
P Pamies, B Webber, E Pull

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.113
SEVERE (BUT REVERSIBLE) CERVICAL CORD AND BRAIN IRIS REACTION AFTER DISCONTINUATION OF NATALIZUMAB IN PREGNANCY OF PATIENT WITH MULTIPLE SCLEROSIS
Tom Massey, Owen Pearson

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.33
EARLY PREDICTION OF LONG-TERM RESPONSE TO NATALIZUMAB IN MULTIPLE SCLEROSIS
Joel Raffel, Arie Gafson, Samer Dahdaleh, Richard Nicholas

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.118
THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS: A MULTI-ARM, MULTI-CENTRE TRIAL OF NEUROPROTECTION
Jeremy Chataway, Siddharthan Chandran, David Miller, Gavin Giovannoni, Claudia Wheeler-Kingshott, Sue Pavitt, Nigel Stallard, Clive Hawkins, Basil Sharrack, for the MS-SMART trialists

Journal of Neurology, Neurosurgery & Psychiatry Nov 2015, 86 (11) e4; DOI: 10.1136/jnnp-2015-312379.105

Main menu

Multiple sclerosis

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Multiple sclerosis

Pages